top of page

Product Pipeline

RSSERIESA.png

Partners

image 2.png
SHEBA_LOGO_ENG_NEW.png
SHEBA_LOGO_ENG_NEW_edited.png
rambam-logo-25.png
image (7) 2.png
Untitled design (14).png
image (5) 1.png
image (4) 1.png
Daco_1736779.png

ExhalePN was studied in early-clinical settings and is now entering a training study with FDA approval expected in 2024. 

Scientific Advisory Board

bottom of page